The presence of mRNA and protein expression of histamine H3R led us to investigate the effects of different H3R antagonists (GSK189254, ciproxifan and DL 76) on IOP reduction in models of ocular hypertension. This evidence concerns the gene HRH3 and ocular hypertension.